Ryland Byrd
Pulmonary Disease · Mountain Home, TNNPI 1659308112
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 246 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by GSK at 34.0% of the total. That places this record below the midpoint for pulmonary disease clinicians in TN, where the typical reported total is $3,628.
Across 246 payments — averaging $16.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$909
- Insmed, Inc.$193
- Boehringer Ingelheim$191
- Sanofi$180
- Genentech USA, Inc.$164
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,84095%
- Education$2005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 102 | $1,375 |
| AstraZeneca | 53 | $909 |
| Insmed, Inc. | 6 | $193 |
| Boehringer Ingelheim | 10 | $191 |
| Sanofi | 8 | $180 |
| Genentech USA, Inc. | 10 | $164 |
| Sunovion Pharmaceuticals Inc. | 9 | $149 |
| Mallinckrodt Hospital Products Inc. | 3 | $142 |
| Grifols USA, LLC | 6 | $133 |
| Philips North America LLC | 7 | $111 |
| Regeneron Healthcare Solutions, Inc. | 5 | $81 |
| Circassia Inc. | 5 | $66 |
| Novartis | 4 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Mylan Specialty L.p. | 3 | $45 |
| Baxter Healthcare | 2 | $38 |
| United Therapeutics Corporation | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Pfizer | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Merck | 1 | $16 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| Electromed, Inc. | 2 | $15 |
| Amgen | 1 | $14 |
| Inogen, Inc. | 2 | $12 |
How this compares
$4,040 in reported general payments places this provider in the 50th percentile of 339 pulmonary disease providers in Tennessee.
Other pulmonary disease in Mountain Home
- Lisa LancasterNashville$519K
- Krishnendu BhadraChattanooga$494K
- Aaron MilstoneFranklin$482K
- Otis RickmanNashville$392K
- Michael CzarneckiChattanooga$348K
- Susan GarwoodNashville$343K
- Girendra HoskereBristol$285K
- Carlos BaleeiroChattanooga$265K
- Joao DeandradeNashville$245K
- John SwisherKnoxville$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.